Chrysos Corporation Limited (ASX:C79) has secured firm commitments for an AU$75 million institutional Placement, fortifying its position to expand deployment of PhotonAssayTM units and fuel accelerated growth. This move closely follows their global partnership with Barrick Gold and MSALABS, enabling the potential deployment of up to 13 PhotonAssayTM units across Barrick mine sites on four continents by DY2025.
Upon settlement, Chrysos anticipates a robust cash balance of approximately AU$108 million and AU$22 million in untapped debt capacity, strengthening its financial standing. The company is in advanced talks to extend its debt facilities. These funds not only support Chrysos' existing deployment commitments but also offer flexibility to enhance annual deployment capacity in line with the expanding sales pipeline. The successful Placement, involving approximately 11.4 million new fully paid ordinary shares at AU$6.60 per share, ensures a well-capitalized Chrysos ready to meet its strategic objectives.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 20, 2024
Nov 20, 2024
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
